hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome
暂无分享,去创建一个
Yundai Chen | W. Dong | Zhenhong Fu | Xia Yang | G. Qian | Jun Guo | Yundai Chen | Lian Chen | M. Shen | H. Xue | Zhenhong Fu | lian Chen
[1] Xiao-ming Shang,et al. Correlation Between Hyperhomocysteinemia and Outcomes of Patients With Acute Myocardial Infarction , 2016, American journal of therapeutics.
[2] H. Suryapranata,et al. Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid , 2015, Journal of cardiovascular pharmacology.
[3] L. Sechi,et al. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients. , 2015, American journal of hypertension.
[4] S. Fu,et al. Multimarker Analysis for New Biomarkers in Relation to Central Arterial Stiffness and Hemodynamics in a Chinese Community-Dwelling Population , 2015, Angiology.
[5] A. Levi,et al. Assessment of a Possible Link Between Hyperhomocysteinemia and Hyperuricemia , 2015, Journal of Investigative Medicine.
[6] Silvia Lai,et al. Early markers of cardiovascular risk in chronic kidney disease , 2015, Renal failure.
[7] Yundai Chen,et al. Correlation between comprehensive evaluation of coronary artery lesion severity and long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome. , 2014, Heart, lung & circulation.
[8] A. Esteghamati,et al. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease. , 2014, Journal of cardiology.
[9] E. Akbal,et al. Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level. , 2014, Archives of medical research.
[10] H. Suryapranata,et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. , 2014, Thrombosis research.
[11] H. Zhang,et al. Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia , 2014, Journal of Human Hypertension.
[12] A. Miled,et al. Clinical Utility of Serum Cystatin C in Predicting Coronary Artery Disease in Patients Without Chronic Kidney Disease , 2014, Journal of clinical laboratory analysis.
[13] Yundai Chen,et al. Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus , 2013, Cardiovascular Diabetology.
[14] J. Drzewoski,et al. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. , 2013, Pharmacological research.
[15] Y. Hu,et al. Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China , 2013, Herz.
[16] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[17] D. Levy,et al. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study , 2012, Circulation.
[18] S. Tyagi,et al. Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role? , 2010, PPAR research.
[19] Saskia le Cessie,et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study , 2009, BMJ : British Medical Journal.
[20] J. Manson,et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.
[21] Fang Wang,et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[23] Song-min Huang,et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[24] Per Magne Ueland,et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.
[25] S. Tyagi,et al. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation , 2004, Nutrition journal.
[26] G A Beller,et al. Demographics and cardiology, 1950-2050. , 2000, Journal of the American College of Cardiology.
[27] G. Gensini,et al. A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.
[28] Mark D. Huffman,et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.
[29] Maarten L. Simoons,et al. The third universal definition of myocardial infarction , 2013 .
[30] Georgia Salanti,et al. Homocysteine lowering interventions for preventing cardiovascular events. , 2009, The Cochrane database of systematic reviews.
[31] E. Falk,et al. Homocysteine and atherothrombosis , 2001, Lipids.